You just read:

Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy

News provided by

Amylin Pharmaceuticals, Inc.

Dec 20, 2010, 08:00 EST